B · Normal
[The concept of innovative drugs rebounded in shock, and Salem Biotech rose by more than 10%] On September 28, the concept of innovative drugs rebounded in shock, with Salem Biotech rising by more than 10%, and nearshore protein rose by more than 7%, hitting a record high. Previously, Livzon Group hit its daily limit, and Sanyuan Gene, Yiyi Pharmaceutical, Puluo Pharmaceutical, and Tigermed followed suit. On the news, on September 24, local time, Swedish atomic layer deposition (ALD) technology company Nanexa issued a statement saying that the company had reached a drug delivery technology cooperation agreement with Novo Nordisk for a maximum amount of 1.165 billion euros.
Live broadcast 🕐 2026-09-28 09:58
#atom #Gene #Live broadcast #Innovative drugs
Save as Image Generate a beautiful long image to share on Moments or in group chats Generate now ⬇
← Back to Telegraph

Related telegraphs

[The Hang Seng Technology Index closed down 0.37%, with optical communications s 09-28 16:10 [Analysis of listed stocks on September 28: The promotion rate of listed stocks 09-28 15:33 [Analysis of daily limit on September 28] On September 28, a total of 33 stocks 09-28 15:11 [Comment: Both the mass entrepreneurship and innovation index fell by more than 09-28 15:02 [Wind power equipment sector fluctuated and rebounded, Jixin Technology 2-link b 09-28 14:26 [Main Fund Monitoring: Net outflows from the electronics sector exceed 26.3 bill 09-28 14:26

Comments

0/500
Captcha (click to refresh)
No comments yet